image

Transverse Medical Inc. (TMI) is developing the POINT-GUARD™ Dynamic Cerebral Embolic Protection (CEP) medical device to address the devastating and costly problem of stroke during the large and growing number of heart valve procedures that occur annually around the world, such as Transcatheter Aortic Valve Replacement (TAVR).

POINT-GUARD™ is a highly differentiated and proprietary medical device designed to more effectively provide maximum filter coverage to protect the brain, minimize embolic particles from the cerebral flow, and minimize the risk of stroke.

*POINT-GUARD™ is not cleared for sale by any regulatory authority.

Company’s Keywords:

cerebral embolic protection, transcatheter aortic valve, surgical aortic valve, medical device development

Q How Many Employees Does This Company Have?

5

Q Which Industry Does This Company Belong To?

medical devices

Q What Is the Annual Income?

1000000

Q What Is the Technology of All the Company’s Website?

Outlook, Typekit, Mobile Friendly, YouTube, Squarespace ECommerce, Nginx

Q What Year Was the Company Founded?

2011

Rate us and Write a Review

Your review is recommended to be at least 140 characters long

image

building Own or work here? Claim Now! Claim Now!

imageYour request has been submitted successfully.

image